Miyoun Yoo
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.
Journal: Scientific reports
Published: March 23, 2023
Discovery of BET specific bromodomain inhibitors with a novel scaffold.
Journal: Bioorganic & medicinal chemistry
Published: June 24, 2022
Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.
Journal: Molecules (Basel, Switzerland)
Published: February 18, 2021
Toxicity of the recombinant human hyaluronidase ALT-BC4 on embryonic development.
Journal: Journal of animal science and technology
Published: December 02, 2020
Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects.
Journal: Oncology letters
Published: August 10, 2020
Biotechnological Potential of Rhodococcus Biodegradative Pathways.
Journal: Journal of microbiology and biotechnology
Published: June 19, 2018
A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening.
Journal: Biochemical and biophysical research communications
Published: June 11, 2018
Synthesis and biological evaluation of indazole-4,7-dione derivatives as novel BRD4 inhibitors.
Journal: Archives of pharmacal research
Published: August 11, 2017
Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: May 04, 2017
Anthranilate degradation by a cold-adapted Pseudomonas sp.
Journal: Journal of basic microbiology
Published: January 24, 2013
Characterization and engineering of an o-xylene dioxygenase for biocatalytic applications.
Journal: Bioresource technology
Published: December 02, 2012
Last Updated: 09/26/2026